Development and License AgreementDevelopment and License Agreement • January 14th, 2003 • Immunogen Inc • Pharmaceutical preparations
It is the intention of the parties that the Technical Transfer Plan referenced in Section 5.2 of this Agreement will be finalised by the parties as soon as practicable and in any event no later than May 31, 2002. Both parties agree to negotiate such finalized terms in good faith, which shall be based on the transfer by ImmunoGen to BI of following documentation, to the extent available:
